Infigratinib Phosphate Patent Expiration

Infigratinib Phosphate was first introduced by Helsinn Healthcare Sa in its drug Truseltiq on May 28, 2021.


Infigratinib Phosphate Patents

Given below is the list of patents protecting Infigratinib Phosphate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Truseltiq US10278969 Pharmaceutical dosage forms Dec 11, 2034 Helsinn Hlthcare
Truseltiq US11160804 Pharmaceutical dosage forms Dec 11, 2034 Helsinn Hlthcare
Truseltiq US8552002 Compounds and compositions as protein kinase inhibitors Aug 25, 2029 Helsinn Hlthcare
Truseltiq US9067896 Crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl) -phenylamino]-pyrimidin-4-yl}-1-methyl-urea and salts thereof Aug 06, 2028 Helsinn Hlthcare


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳